1. EBOLA Ag K-SeT rapid test: field evaluation in Sierra Leone
F. Colavita, M. Biava, P. Mertens, Q. Gilleman, C. Borlon, M. Delli Guanti, A. Petrocelli, G. Cataldi, A.T. Kamara, S.A. Kamara, K. Konneh, D. Vincenti, C. Castilletti, S. Abdurahman, A. Mirazimi, M.R. Capobianchi, G. Ippolito, R. Miccio, A. Di Caro 
Clinical Microbiology and Infection 
Volume 24, Issue 6, Pages (June 2018)
DOI: /j.cmi
Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

2. Fig. 1
EBOLA Ag K-SeT, lateral flow immunoassay, detecting Ebola virus Zaire strain VP40 viral matrix protein. Rapid antigen test is operated by introduction of 30 μL of plasma or serum, or 50 μL of whole blood, onto centre of sample pad. After inserting four drops (approximately 150 μL) of sample buffer in pad, flow of sample and sample buffer initiates. Visual interpretation of results is performed after 15 minutes' incubation time. Capture of antigen by EBOV VP40–specific antibodies composing test line (T) results in development of red signal. In case of EBOV antigen-negative samples, gold conjugate is captured only by control line, indicating valid result. EBOLA Ag K-SeT showing failed control (C) line are considered invalid. EBOV, Ebola virus.
Clinical Microbiology and Infection  , DOI: ( /j.cmi )
Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

3. Fig. 2
Diagnostic algorithm integrating RDT test for management of EVD suspected cases during triage. EVD, Ebola virus disease; RT-PCR, reverse transcription–PCR.
Clinical Microbiology and Infection  , DOI: ( /j.cmi )
Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions